Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Boston, MA
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Ann Arbor, MI
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Kalamazoo, MI
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Midland, MI
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Midland, MI
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Muskegon, MI
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Muskegon, MI
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Petoskey, MI
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Petoskey, MI
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Duluth, MN
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Duluth, MN
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Rochester, MN
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Kansas City, MO
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Paramus, NJ
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Paramus, NJ
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
New York, NY
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Rochester, NY
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Chapel Hill, NC
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Toledo, OH
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Hershey, PA
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Hershey, PA
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Providence, RI
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Germantown, TN
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Germantown, TN
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Oak Ridge, TN
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Oak Ridge, TN
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Dallas, TX
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Houston, TX
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Richmond, VA
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated:  6/1/2016
mi
from
Calgary,
A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease
A Multi-Center, Double-blind, Randomized, Placebo Controlled, Parallel Group Study of the Effect of Dalcetrapib on Atherosclerotic Disease Progression As Measured by Coronary Intravascular Ultrasound, Carotid B-Mode Ultrasound and Coronary Angiography
Status: Enrolling
Updated: 6/1/2016
mi
from
Calgary,
Click here to add this to my saved trials
Screening and Access to Health Care for Vascular Disease
Screening and Access to Health Care for Vascular Disease in Urban and Suburban Patient Populations
Status: Enrolling
Updated:  6/1/2016
NorthShore University HealthSystem
mi
from
Evanston, IL
Screening and Access to Health Care for Vascular Disease
Screening and Access to Health Care for Vascular Disease in Urban and Suburban Patient Populations
Status: Enrolling
Updated: 6/1/2016
NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Indianapolis, IN
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Iowa City, IA
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Louisville, KY
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Bethesda, MD
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Minneapolis, MN
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Statesville, NC
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Statesville, NC
Click here to add this to my saved trials
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Cincinnati, OH
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
A Phase II, Placebo-Controlled, Double-Blind Extension Study of Study NC19453 Assessing Long-term Safety and Efficacy of RO4607381
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra
A Phase I Placebo-Controlled, Open-Label, Crossover Study to Assess the Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra in Healthy Volunteers
Status: Enrolling
Updated:  6/6/2016
Thomas Jefferson University Hosptial
mi
from
Philadelphia, PA
Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra
A Phase I Placebo-Controlled, Open-Label, Crossover Study to Assess the Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra in Healthy Volunteers
Status: Enrolling
Updated: 6/6/2016
Thomas Jefferson University Hosptial
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
Heart Center Research, Llc
mi
from
Huntsville, AL
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
Heart Center Research, Llc
mi
from
Huntsville, AL
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
Heart Center Research, Llc
mi
from
Huntsville, AL
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
Heart Center Research, Llc
mi
from
Huntsville, AL
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
James A Haley Veterans' Center
mi
from
Tampa, FL
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
James A Haley Veterans' Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
The Heart Group/Deaconess
mi
from
Evansville, IN
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
The Heart Group/Deaconess
mi
from
Evansville, IN
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
Iowa Heart Center, P.C.
mi
from
West Des Moines, IA
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
Iowa Heart Center, P.C.
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
Delmarva Heart Foundation
mi
from
Salisbury, MD
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
Delmarva Heart Foundation
mi
from
Salisbury, MD
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
Beth Israel Deaconess
mi
from
Boston, MA
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
Beth Israel Deaconess
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
Washington University Medical School
mi
from
Saint Louis, MI
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
Washington University Medical School
mi
from
Saint Louis, MI
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
St. John Providence Hospital
mi
from
Southfield, MI
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
St. John Providence Hospital
mi
from
Southfield, MI
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
Lester E. Cox Medical Center
mi
from
Springfield, MO
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
Lester E. Cox Medical Center
mi
from
Springfield, MO
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
The Valley Hospital
mi
from
Ridgewood, NJ
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
The Valley Hospital
mi
from
Ridgewood, NJ
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
Associated Cardiovascular Consultants/Lourdes Cardiology Services
mi
from
Voorhees, NJ
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
Associated Cardiovascular Consultants/Lourdes Cardiology Services
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
North Shore LIJ
mi
from
New York, NY
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
North Shore LIJ
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
New York-Presbyterian Hospital
mi
from
New York, NY
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
New York-Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
Northeast Ohio Cardiovascular Specialists
mi
from
Akron, OH
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
Northeast Ohio Cardiovascular Specialists
mi
from
Akron, OH
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
The Lindner Research Center
mi
from
Cincinnati, OH
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
The Lindner Research Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
Bethesda North Hospital
mi
from
Cincinnati, OH
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
Bethesda North Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated:  6/7/2016
Cleveland Clinic
mi
from
Cleveland, OH
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
Risk Estimation Following Infarction Noninvasive Evaluation - ICD Efficacy
Status: Enrolling
Updated: 6/7/2016
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials